Let's take a look at the major Medical product stocks slated to release their quarterly reports on Oct 25.
Honeywell International Inc. (HON) reported strong third-quarter 2016 results.
Despite a challenging macroeconomic environment, sustained restructuring initiatives for a leaner firm with a re-focus on core operations enabled General Electric Company (GE) to report relatively healthy third-quarter 2016 results.
Danaher Corporation (DHR) reported adjusted earnings of 87 cents a share in third-quarter 2016, beating the Zacks Consensus Estimate of 83 cents by 4.8%.
Danaher Corporation's (DHR) adjusted earnings per share for the third-quarter of 2016 came in at 87 cents, which beat the Zacks Consensus Estimate of 83 cents.
Danaher Corp. (DHR) is set to report third-quarter 2016 earnings results before the opening bell on Oct 20.
Cepheid (CPHD) is scheduled to report third-quarter 2016 results on Oct 18, after market close.
T. Rowe Price Capital Appreciation Advisor (PACLX) a Zacks Rank #1 (Strong Buy) invests at least 50% of its total assets in stocks
The Zacks Analyst Blog Highlights: BP, Berkshire Hathaway, Cognizant, eBay and Danaher
We issued an updated research report on Crane Co. (CR) on Sep 28, 2016.
CLARCOR Inc. (CLC) recently hiked its quarterly dividend to 25 cents per share from 22 cents, representing a 14.0% year-over-year increase.
The Zacks Analyst Blog Highlights: Verizon, EOG Resources, Danaher and Spectra Energy
Danaher's offer price of $53 per share marks a 54% premium over Cepheid's share price at market close on Friday, Sep 2.
Danaher (DHR) has inked a definitive agreement to buy molecular diagnostics company Cepheid (CPHD) for about $4 billion.